Search Results
Search this site
191 results found
- How Your Vaginal Microbiota Transforms During Your Menstrual Cycle
The menstrual cycle is a recurring process, usually lasting about 28 days. It has four key phases: menstrual, follicular, ovulation, and luteal, each regulated by hormonal changes. These hormonal shifts not only impact reproductive functions but also influence various aspects of a woman's health, including the composition and balance of the vaginal microbiota, which can fluctuate throughout the cycle. What we know: Lactobacillus species are among the most common colonizers of the vaginal tract in women of reproductive age and are recognized as key components of a healthy vaginal microbiome (Krog et al ., 2022). Lactobacillus is thought to defend against infections and maintain a healthy vaginal epithelium by producing lactic acid, which lowers the vaginal pH and makes it difficult for pathogenic bacteria to grow (Song et al ., 2020). Menstrual blood neutralizes the acidic vaginal environment, raising the pH, which promotes the growth of anaerobic bacteria like Streptococcus and Gardnerella , while reducing Lactobacillus populations, and the iron in menstrual blood also nourishes certain bacteria (Shen et al ., 2022). Women with unstable Vaginal Community Dynamics (VCDs) showed higher phage counts, often dominated by Lactobacillus iners , and had Gardnerella spp strains more likely to carry bacteriocin-coding genes (Hugerth et al ., 2024). Menstruation triggers an inflammatory response characterized by increased cytokine production and a higher accumulation of mature, activated neutrophils in the vagina, alongside an increase in Streptococcaceae (Adapen et al ., 2022). Industry impact & potential: Modifying the vaginal microbiota with antibiotics or probiotics could be beneficial , and recognizing effective therapeutic strategies for these modifications is important (Adapen et al ., 2022). Our solution: At Sequential, we have assembled a dedicated team of scientists who have meticulously studied the human microbiome including the vaginal microbiome. With experience collaborating with many clients worldwide, we are well-prepared to partner with your company on intimate female health applications, microbiome testing, in vivo and clinical certification, and formulation support. Reference: Adapen C, Réot L, Nunez N, Cannou C, Marlin R, Lemaître J, d'Agata L, Gilson E, Ginoux E, Le Grand R, Nugeyre MT, Menu E. Local Innate Markers and Vaginal Microbiota Composition Are Influenced by Hormonal Cycle Phases. Front Immunol. 2022 Mar 25;13:841723. doi: 10.3389/fimmu.2022.841723. PMID: 35401577; PMCID: PMC8990777. Hugerth, L.W., Krog, M.C., Vomstein, K. et al. Defining Vaginal Community Dynamics: daily microbiome transitions, the role of menstruation, bacteriophages, and bacterial genes. Microbiome 12, 153 (2024). https://doi.org/10.1186/s40168-024-01870-5 Krog MC, Hugerth LW, Fransson E, Bashir Z, Nyboe Andersen A, Edfeldt G, Engstrand L, Schuppe-Koistinen I, Nielsen HS. The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle. Hum Reprod. 2022 Jun 30;37(7):1525-1543. doi: 10.1093/humrep/deac094. PMID: 35553675; PMCID: PMC9247429. Shen L, Zhang W, Yuan Y, Zhu W, Shang A. Vaginal microecological characteristics of women in different physiological and pathological period. Front Cell Infect Microbiol. 2022 Jul 22;12:959793. doi: 10.3389/fcimb.2022.959793. PMID: 35937699; PMCID: PMC9354832. Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MRSTetel MJ, Chia N 2020. Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise. mSphere5:10.1128/msphere.00593-20. https://doi.org/10.1128/msphere.00593-20
- Microbiome Matters: The Implications of Diabetes on the Oral Microbiome
Diabetes mellitus is a recognised risk factor for the development of periodontitis, a gum disease that is characterised by the damage of the soft tissue surrounding the teeth. While the connection between diabetes and oral health is well-documented, targeted research on the oral microbiome in diabetes patients has historically been limited. What We Know: The interplay between diabetes and periodontitis is bidirectional: poorly managed diabetes results in elevated blood sugar (glucose) levels in oral fluids, promoting the growth of bacteria that can lead to gum disease. Conversely, untreated periodontal infections can raise blood sugar levels, complicating diabetes management (Xiao et al., 2017) . Diabetes also alters the composition of oral bacteria. Studies involving the transfer of oral microbiota from diabetic mice to germ-free mice demonstrate that the microbiota from diabetic mice is more pathogenic. These diabetic mice exhibited increased levels of bacteria such as Proteobacteria (Enterobacteriaceae) and Firmicutes (Enterococcus, Staphylococcus and Aerococcus) which are all associated with periodontitis and impaired healing in diabetic conditions (Xiao et al., 2017) . Industry Impact and Potential: IL-17 is a versatile cytokine involved in both immune defence and pathological immune responses. Elevated levels of IL-17 are observed in chronic periodontitis, where it triggers the production of pro-inflammatory mediators like IL-6 and RANKL, potentially leading to increased osteoclastogenesis, which contributes to bone loss (Xiao et al., 2016) . Research has shown that treatment with IL-17 antibodies can reduce the pathogenicity of the oral microbiome in diabetic mice. When the oral microbiota from IL-17-treated diabetic mice was transferred to germ-free mice, the recipients showed lower levels of neutrophil recruitment, decreased inflammatory markers like IL-6 and RANKL, and reduced bone resorption. This suggests that IL-17 treatment may mitigate the harmful effects associated with the oral microbiota in diabetes (Xiao et al., 2017) . @Frezyderm offers a specially designed oral care range for diabetics, utilising the combination of bioactive peptides and hyaluronic acid in their products. This formulation aims to regulate glucose levels in the mouth, while also reducing bone loss, combating dental plaque, hydrating and healing the gums, as well as preventing cavity formation. Our Solution: At Sequential, we specialise in microbiome analysis and product development across the oral, skin, scalp and vaginal areas, pioneering innovative solutions that support and preserve the microbiome. With our extensive expertise, we are well-equipped to collaborate with your company in developing products that promote a healthy oral microbiome and overall oral health, for example, protecting against diabetes-associated dysbiosis. References: Xiao, E., Mattos, M., Vieira, G.H.A., Chen, S., Corrêa, J.D., Wu, Y., Albiero, M.L., Bittinger, K. & Graves, D.T. (2017) Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity. Cell Host & Microbe. 22 (1), 120-128.e4. doi:10.1016/j.chom.2017.06.014. Xiao, W., Li, S., Pacios, S., Wang, Y. & Graves, D.T. (2016) Bone Remodeling Under Pathological Conditions. Frontiers of Oral Biology. 18, 17–27. doi:10.1159/000351896.
- Crazy for Coconut: Can Hair Oiling Transform Your Scalp Microbiome?
Hair and scalp oiling, a traditional Ayurvedic practice with ancient roots, is revered for its holistic health benefits. Today, this ritual is gaining popularity in modern, westernised cosmetic routines, particularly with coconut oil (CO), and emerging research is exploring its potential to influence the scalp microbiome. What We Know: Traditional hair oiling involves applying specific oils, often warmed, to the scalp and hair roots, followed by massage and leaving the oil to penetrate for several hours or days before washing. While CO, derived from Cocos nucifera , is especially popular, other oils like almond, castor, argan, olive, fenugreek, sesame, flaxseed and mustard have also been historically used (Mysore & Arghya, 2022) . The chemical composition of CO includes saturated fatty acids, making it a rich source of medium-chain fatty acids, with major components like myristic acid, capric acid, lauric acid and monolaurin. It also contains phenolic acids and antioxidants, such as tocopherol (Mysore & Arghya, 2022) . CO is prized for its cleansing, protective and restorative properties in haircare. It functions as a saponification agent in shampoos and has antibacterial and antifungal benefits against Cutibacterium acnes and Staphylococcus aureus due to its monolaurin content. Acting as an emollient, CO seals the hair cuticle and locks in moisture. Additionally, its low molecular weight and linear chain structure enable it to penetrate the hair shaft, aiding in the prevention of protein loss (Mysore & Arghya, 2022) . Industry Impact and Potential: A longitudinal study of the scalp microbiome showed that CO may positively influence the scalp microbiome. CO application to the scalp increased beneficial bacteria like C. acnes and fungi like Malassezia globosa , both of which are linked to healthier scalp conditions and reduced dandruff symptoms. The study also found that CO enriches bacterial pathways related to scalp health, such as biotin metabolism, while decreasing fungal pathogenesis pathway (Saxena et al., 2021) . Various hair care brands have developed scalp oiling products that incorporate CO. However, further research into how products like these may be optimised to benefit the scalp microbiome is largely unexplored and may offer a promising avenue of untapped research and commercial development in the cosmetics industry. Our Solution: With an extensive database comprising over 20,000 microbiome samples and 4,000 ingredients, alongside a global network of more than 10,000 testing participants, Sequential delivers thorough services for assessing product impacts and formulations. Our dedication to creating products that maintain microbiome integrity make us the ideal partner for your scalp and hair care product development needs, including the exploration of oil-based products. References: Mysore, V. & Arghya, A. (2022) Hair Oils: Indigenous Knowledge Revisited. International Journal of Trichology . 14 (3), 84–90. doi:10.4103/ijt.ijt_189_20. Saxena, R., Mittal, P., Clavaud, C., Dhakan, D.B., Roy, N., Breton, L., Misra, N. & Sharma, V.K. (2021) Longitudinal study of the scalp microbiome suggests coconut oil to enrich healthy scalp commensals. Scientific Reports . 11 (1), 7220. doi:10.1038/s41598-021-86454-1.
- Unlocking the Power of Skin Microbiome Transplantation: Can It Transform Your Skin Health?
Skin microbiome transplantation is an emerging therapeutic approach designed to restore a healthy balance of microbial communities on the skin, especially in relation to various dermatological conditions. Recent research has underscored the crucial role of the skin microbiome in maintaining skin health and its contribution to the development of skin diseases like atopic dermatitis, psoriasis, and acne vulgaris. By transplanting healthy skin microbiota, it may be possible to reverse dysbiosis in microbial populations that can trigger inflammatory skin conditions. What we know: Transplantation can involve transferring whole skin microbiota from a healthy individual or using an artificial mixture of selected microorganisms (Junca et al ., 2022). The transplantation method is influenced by the interplay between donor microbiome composition, recipient microbiome composition, and transplant load, with certain combinations enhancing engraftment (Boxberger et al ., 2021). Studies have shown that transferring entire skin microbiomes between different body sites can replicate specific microbial effects, such as odour-causing bacteria could be transferred from the armpit to the forearm (Callewaert et al ., 2021). Transfer of microbiome swabs from the arm to the upper back, found greater diversity in the inner elbow compared to the back. Four arm-specific species persisted on the back after 24 hours, mainly from Gardnerella , Brachybacterium , and Actinomyces (Callewaert et al ., 2021). In a clinical study, siblings were enrolled, including one with strong body odour. The skin microbiome from the non-odorous sibling was successfully transferred, resulting in reduced body odour and a new microbial balance with more staphylococci and fewer corynebacteria (Callewaert et al ., 2021). Industry impact & potential: Transferring live microorganisms from healthy donors to patients poses risks, necessitating pathogen screening standards (Junca et al ., 2022). Standardization of microbiome collection, preparation, and storage methods is essential for assessing transplantation efficacy (Junca et al ., 2022). Understanding microbiome interactions and pathofunctions will support personalized therapeutic strategies targeting specific skin microbiota functions (Junca et al ., 2022). Our solution: Sequential is a company focused on skin microbiome testing, utilizing advanced sequencing technologies to analyze skin microbial communities. We offer valuable insights into the microbiome profiles of individuals skin, enabling the development of personalized treatment plans. By collaborating with dermatologists and researchers, we contribute significantly to the advancement of microbiome-based diagnostics and therapeutics. Reference: Boxberger, M., Cenizo, V., Cassir, N . Challenges in exploring and manipulating the human skin microbiome. Microbiome 9, 125 (2021). https://doi.org/10.1186/s40168-021-01062-5 Callewaert C, Knödlseder N, Karoglan A, Güell M, Paetzold B. Skin microbiome transplantation and manipulation: Current state of the art. Comput Struct Biotechnol J. 2021 Jan 4;19:624-631. doi: 10.1016/j.csbj.2021.01.001. PMID: 33510866; PMCID: PMC7806958. Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Comput Struct Biotechnol J. 2022 Jan 19;20:615-627. doi: 10.1016/j.csbj.2022.01.009. PMID: 35140882; PMCID: PMC8801967.
- The Microbial Link to Endometriosis: What’s Happening in Your Vaginal Flora?
Endometriosis affects around 196 million women worldwide, causing chronic pelvic pain and infertility. This estrogen-dependent condition involves endometrial tissue growing outside the uterus, impacting 6-10% of reproductive-age women. Symptoms include severe cramps, painful intercourse, and pelvic discomfort. Emerging research suggests a link between the urogenital and gastrointestinal systems in its development. (Ser et al ., 2023). What we know: Dysbiosis and infections in the female genital tract can lead to genetic and epigenetic changes that promote oxidative stress and alter immune responses, contributing to the development of endometriosis, with factors like Mycoplasma genitalium colonization and inflammation influencing gene expression and DNA methylation patterns (Uzuner et al ., 2023). The Estrobolome, involved in estrogen metabolism, impacts endometriosis by altering the vaginal microbiota, with hormonal contraceptives shown to restore normal microbiota and reduce dysbiosis linked to the condition (Zizolfi et al ., 2023). The "bacterial contamination" theory suggests that elevated E. coli levels in menstrual blood contribute to endometriosis progression by introducing endotoxins that cause inflammation, with increased Proteobacteria (Uzuner et al ., 2023). Studies reveal distinct changes in the vaginal microbiome of endometriosis patients, with a lower abundance of Lactobacillus and higher levels of bacteria like Corynebacterium , Enterobacteriaceae , and Streptococcus , especially in advanced stages (Ser et al ., 2023). Endometriosis patients show reduced beneficial gut bacteria Clostridia , Ruminococcus and increased harmful ones Eggerthella lenta , Eubacterium dolicum . The peritoneal microbiome also has elevated Methylobacterium and Streptococcus , suggesting their role in the disease (Ser et al ., 2023). Industry impact & potential: Probiotics like Lactobacillus gasseri OLL2809 and multi-strain formulations such as LactoFem® may help manage endometriosis by reducing symptoms and inflammation. However, more research is needed to optimize their use and understand their impact on microbiome stability (Ser et al ., 2023). More research needs to be done on identifying key microbial species linked to endometriosis, exploring their roles in immune activation and microbiota disruption, and understanding the causal relationships between dysbiosis and estrogen metabolism Our solution: The delicate balance of the vaginal microbiome can be disrupted by the use of inappropriate intimate care products, leading to undesirable conditions. Sequential is committed to uncovering the true effects of formulations on the microbiome in various human conditions, such as Endometriosis. We carry out testing to ensure that vaginal care products are effective in addressing specific concerns while remaining gentle and supportive of the natural microbial community. Reference: Ser HL, Au Yong SJ, Shafiee MN, Mokhtar NM, Ali RAR. Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review. Microorganisms. 2023 Jan 31;11(2):360. doi: 10.3390/microorganisms11020360. PMID: 36838325; PMCID: PMC9962481. Uzuner C, Mak J, El-Assaad F, Condous G. The bidirectional relationship between endometriosis and microbiome. Front Endocrinol (Lausanne). 2023 Mar 7;14:1110824. doi: 10.3389/fendo.2023.1110824. PMID: 36960395; PMCID: PMC10028178. Zizolfi B, Foreste V, Gallo A, Martone S, Giampaolino P, Di Spiezio Sardo A. Endometriosis and dysbiosis: State of art. Front Endocrinol (Lausanne). 2023 Feb 20;14:1140774. doi: 10.3389/fendo.2023.1140774. PMID: 36891056; PMCID: PMC9986482.
- The Gut-Brain Axis: How Your Microbiome Holds the Key to Mental Health
Introduction: The gut-brain axis The gut-brain axis is a two-way communication network between the digestive system and the brain, involving hormones, metabolism, the immune system, and other pathways. Key components include the autonomic nervous system, the hypothalamic-pituitary-adrenal (HPA) axis, and gut nerves that link the brain to digestion and immune responses. The gut can also influence mood, cognition, and mental health (Appleton, 2018). Gut bacteria play a crucial role in this relationship, affecting mental health, emotional regulation, and the HPA axis. Changes in the gut microbiome have been linked to mood disorders like anxiety and depression, as well as gastrointestinal (GI) diseases like irritable bowel syndrome, which often coincide with psychological conditions. Gut microbiota also impact brain development in fetuses and newborns, and diet influences how the gut microbiome affects cognitive functions (Appleton, 2018). Depression Depression is a mood disorder characterized by feelings of sadness, emptiness, or irritability, leading to a loss of interest in daily activities. It can cause both mental and physical changes that interfere with everyday life. In the U.S., depression contributes to nearly 40,000 suicides each year, with older men being at the highest risk (Chand & Arif, 2023). Depression can affect anyone, regardless of age or social background, impacting both women and men. If symptoms persist for more than two weeks, it may indicate depression ( InformedHealth.org , 2020). Major Depressive Disorder (MDD) has multiple causes, including biological, genetic, environmental, and psychological factors. While it was initially thought to be due to imbalances in neurotransmitters like serotonin, norepinephrine, and dopamine, newer research suggests disruptions in complex neural circuits. Other neurotransmitters, such as GABA and glutamate, as well as hormonal imbalances, also play a role. Early life stress and trauma can result in lasting brain changes that contribute to depression. Genetics have a strong influence, especially in twins, and life events, personality traits, and cognitive distortions further increase the risk (Chand & Arif, 2023). Diagnosis of major depression is primarily made through a clinical evaluation, including a detailed interview and mental status examination, and is found to be as reliable as many medical tests (Goldman et al., 1999). The DSM-5 provides specific criteria for diagnosing depression (Regier et al., 2013). Treatment typically involves medication and brief psychotherapy, such as cognitive-behavioral therapy (CBT) or interpersonal therapy. Combining these treatments improves symptom relief and quality of life. CBT is particularly effective in preventing relapse. Despite effective treatments, about 50% of people may not initially respond, and full recovery is uncommon. However, around 40% of patients experience partial improvement within a year (Chand & Arif, 2023). Selective Serotonin Reuptake Inhibitors (SSRIs) Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed medications for treating depression. They are usually the first choice for pharmacotherapy because of their safety, effectiveness, and good tolerance in both adults and children (Chu & Wadhwa, 2023). SSRIs work by increasing the levels of serotonin, also known as 5-hydroxytryptamine (5-HT), in the brain, which is often low in individuals with depression. They do this by blocking the serotonin transporter (SERT) at nerve endings, which prevents the reabsorption (reuptake) of serotonin. This action keeps more serotonin in the brain's synapses, allowing it to have a more prolonged effect on mood (Figure 1). Unlike other antidepressants, SSRIs primarily target serotonin and have minimal impact on other neurotransmitters like dopamine or norepinephrine (Chu & Wadhwa, 2023). Figure 1: A schematic diagram illustrating the mechanism of SSRIs: These medications block the reuptake of serotonin at the presynaptic membrane, leading to increased serotonin levels at the postsynaptic nerve terminal membrane. Image taken from (Lattimore et al., 2005) . Serotonin is also present in the gut mainly at the enterochromaffin (EC) cells of the mucosa. It interacts with various receptors in the gut, the 5-HT3 and 5-HT4 receptors have been most extensively studied for their role in gut motility. It has also been seen that, 5-HT released from EC cells is capable of inducing the mucosal peristaltic reflex and hence propulsive peristalsis (Kendig & Grider, 2015). 5-HT synthesis and gut-brain interaction As mentioned above, serotonin (5-HT) in the gut is produced from tryptophan in enterochromaffin (EC) cells and serotonergic neurons through the actions of tryptophan hydroxylase 1 and 2 (TPH1 and TPH2), converting tryptophan into 5-hydroxytryptophan (5-HTP), which is then turned into serotonin by L-amino acid decarboxylase (L-AADC). This serotonin, along with chromogranin A (CGA), is stored in vesicles via vesicular monoamine transporter 1 (VMAT1). EC cells release serotonin into the extracellular space in response to various stimuli, including chemical and mechanical changes. Most serotonin is released into the extracellular space, with an amount going into the gut lumen. Serotonin is taken up by surrounding enterocytes via the serotonin reuptake transporter (SERT) and then metabolized into 5-hydroxyindoleacetic acid (5-HIAA) by monoamine oxidase (MAO). In serotonergic neurons, serotonin is released into the synaptic cleft, where it acts on postsynaptic receptors and is reabsorbed by SERT. Serotonin is also taken up by endothelial cells and platelets, where it is either converted into 5-HIAA or transported to other tissues (Figure 2) (Liu et al ., 2021). Figure 2: Schematic representation of 5-HT biosynthesis and metabolism. Image taken from (Liu et al., 2021) . The brain-gut hypothesis suggests that serotonin (5-HT) plays a key role in the communication between the gut and the brain. While most serotonin is found in the gut, it also influences brain functions like mood, sleep, and appetite. Imbalances in serotonin levels or receptor activity can result in gastrointestinal issues, such as irritable bowel syndrome (IBS), as well as symptoms in other parts of the body. Research indicates that therapies targeting serotonin can help manage IBS symptoms and related central nervous system dysfunctions (Crowell & Wessinger, 2007). A study investigating the effects of selective serotonin reuptake inhibitors (SSRIs) and the probiotic Lactobacillus rhamnosus JB-1 on gut-brain signaling through the vagus nerve found some interesting results. Using mouse models, researchers observed that oral SSRI treatment activated vagal pathways, which were crucial for reducing anxiety and depression-like behaviors. Similarly, Lactobacillus rhamnosus JB-1 alleviated these behaviors, but its effectiveness was reduced in mice with a severed vagus nerve. This highlights the importance of vagal signaling in gut-brain communication. Both SSRIs and the probiotic also affected the gut microbiota and serotonin levels, suggesting the potential of targeting the gut-brain axis in treating mood disorders like anxiety and depression (McVey et al ., 2019). Comprehensive review: Depressive gut microbiota Depressive Gut Microbiota refers to an imbalanced composition and reduced diversity of microorganisms in the gastrointestinal tract, which has been connected to the development and progression of depression. Studies have shown that individuals with depression exhibit differences in the microbiota community across various taxonomic levels when compared to those without depression, including variations in both α-diversity and β-diversity. At the phylum level, there were inconsistencies in the abundance of Firmicutes , Bacteroidetes , and Proteobacteria , but higher levels of Actinobacteria and Fusobacteria were consistently observed in depressed individuals. On the family level, people with depression had increased levels of families like Actinomycineae , Bifidobacteriaceae , Clostridiaceae , and Streptococcaceae , while families such as Veillonellaceae and Prevotellaceae were less abundant. At the genus level, those with depression showed higher levels of genera like Oscillibacter , Blautia , Streptococcus , and Klebsiella , with lower levels of beneficial bacteria like Coprococcus , Lactobacillus , and Escherichia/Shigella . These changes in gut microbiota composition are evident in those living with depression, and they are associated with inflammation, gut barrier dysfunction, and disruption of gut-brain communication, contributing to depressive symptoms (Barandouzi et al ., 2020). Study 1: Gut Microbiome Patterns Associated With Treatment Response in Patients With Major Depressive Disorder (Bharwani et al ., 2020) The first long-term study to explore a potential link between major depressive disorder (MDD) and the gut microbiome by analyzing microbial patterns before starting antidepressant treatment and during 6 months of therapy. No other research has looked at the microbiota in individuals who have not yet begun antidepressant use (Bharwani et al ., 2020). Results: Microbial differences Fifteen participants (average age 36.9, SD = 12.9; 12 women) were studied. At the start, their average Montgomery–Åsberg Depression Rating Scale (MADRS) score was 22.53 (SD = 6.63). After 6 months, 11 participants were classified as "remitters" (MADRS < 12) and 4 as "nonremitters" (MADRS > 13). Most participants took Escitalopram, while a few took Citalopram (Bharwani et al ., 2020). Baseline diversity of gut microbiota was higher in remitters than in nonremitters (Figure 3). However, there were no differences in variability or community clustering based on treatment response. At baseline, 22 gut microbiota types of operational taxonomic units (OTUs) were different between the two groups. No significant changes in diversity were observed at 3 months, but differences reappeared at 6 months. Within-subject diversity and community composition showed no significant changes over time for either group (Bharwani et al ., 2020). One OTU, a Clostridiales, increased in remitters at 6 months, while no OTUs changed in nonremitters. At 3 months, 35 OTUs were different between the groups, and by 6 months, 42 OTUs showed differences, with some also differing at 3 months. Diet and antidepressant type had no impact on these results (Bharwani et al ., 2020). Figure 3: Baseline differences between eventual responders and nonresponders in alpha-diversity metrics. Image taken from (Bharwani et al., 2020) . Conclusion The study shows that antidepressant treatment impacts the microbiota at the OTU level, based on how well patients respond to treatment. Although overall diversity and microbiota profiles did not change significantly in either group, remitters continued to have higher diversity compared to nonremitters after 6 months. This indicates a potential microbial community signature that differentiates between treatment responders and nonresponders (Bharwani et al ., 2020). Study 2: Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression (Zheng et al ., 2020) Gut microbiome changes are linked to major depressive disorder (MDD) and bipolar disorder (BD), but their specific differences are unclear. This study identifies unique microbial patterns for MDD and BD and offers markers to differentiate between the two based on gut microbiome signatures (Zheng et al ., 2020). Results: Distinct gut microbiome signature in MDD and BD The study compared gut microbiomes across individuals with bipolar disorder (BD), major depressive disorder (MDD), and healthy controls (HC). At the phylum level (Figure 4a), BD had lower Bacteroidetes and higher Proteobacteria compared to MDD and HC. At the family level (Figure 4b), BD showed elevated Pseudomonadaceae , while MDD had higher Bacteroidaceae and Bifidobacteriaceae but lower Enterobacteriaceae than HC. Comparing BD and MDD, BD had more Enterobacteriaceae and Pseudomonadaceae , while MDD showed higher Bacteroidaceae and Veillonellaceae (Zheng et al ., 2020). Figure 4: (a) At the phylum level. (b) At the family level. Image taken from (Zheng et al., 2020) . Results: Gut Microbial Biomarkers for Discriminating MDD, BD, and HC They identified four microbial OTUs, mostly from the Lachnospiraceae family, that were strongly linked to Hamilton Depression Rating Scale (HAMD) scores in MDD and BD patients (Figure 5). These microbial markers helped distinguish between MDD, BD, and healthy controls and also indicated the severity of MDD or BD in patients (Zheng et al ., 2020). Figure 5: Four microbial OTUs, primarily from the Lachnospiraceae family, showed significant links to HAMD scores in MDD and BD patients. Red lines represent positive correlations, while blue lines represent negative correlations, with thicker lines indicating stronger statistical significance (p < 0.05). Image taken from (Zheng et al., 2020) . Conclusion In summary, they identified distinct gut microbiota differences between MDD, BD, and healthy controls. The researchers also found markers that effectively distinguishes MDD from BD and HC. Looking at all these studies, they confirm that there is a connection between the gut and the brain. Role of the Vagus Nerve The vagus nerve is a key part of the parasympathetic nervous system, responsible for regulating essential functions like mood, immune response, digestion, and heart rate. It serves as a communication link between the brain and the gastrointestinal tract, transmitting information about the condition of internal organs to the brain through afferent fibers (Breit et al ., 2018). Issues with the vagus nerve or changes in its function have been linked to a range of gastrointestinal and psychiatric disorders (Breit et al ., 2018). Importance of Vagus Nerve A study demonstrated that the vagus nerve impacts the anxiety-reducing effects of Lactobacillus rhamnosus by acting as a conduit for communication between the gut microbiota and the brain. The study shows that when the vagus nerve is severed, the beneficial effects of L. rhamnosus on anxiety and behavior are lost, indicating that the vagus nerve is essential for transmitting signals from the gut microbiota to the brain. This underscores the nerve’s crucial role in modulating the gut-brain axis, affecting how gut microbiota influence mental health and stress responses (Bravo et al ., 2011). BDNF (Brain-derived neurotrophic factor) BDNF is a protein essential for the growth, maintenance, and survival of neurons in the brain, especially in regions such as the hippocampus, which are critical for memory, learning, and mood regulation. Changes in gut microbiota composition may affect BDNF levels, thereby influencing cognitive functions and neuroplasticity. This underscores the bidirectional relationship between the gut and brain (Agnihotri & Mohajeri, 2022). Lactobacillus in digestive system (Capuco et al., 2020) A study found that patients with major depressive disorder (MDD) who took SSRIs along with the probiotic Lactobacillus plantarum 299v had significantly lower levels of kynurenine, a neurotoxic compound linked to cognitive decline and mood disorders. This group also showed improved cognitive functions, including better attention, perception, and verbal learning, compared to a placebo group. Kynurenine, which can harm the central nervous system, is produced during inflammation triggered by the immune system. The probiotic may have reduced intestinal inflammation, leading to lower kynurenine production and contributing to improved cognition and mood (Capuco et al ., 2020). (Han & Kim, 2019) This study found that isolated Lactobacillus mucosae NK41 and Bifidobacterium longum NK46, derived from human feces, increased levels of brain-derived neurotrophic factor (BDNF) in cells stressed with corticosterone. In mice, both probiotics, alone and in combination, reduced anxiety and depression related to stress, lowered inflammation and stress markers in the brain and blood, and improved gut health. They also decreased populations of Proteobacteria and Bacteroidetes in the gut, as well as bacterial lipopolysaccharide production. These findings suggest that these probiotics may alleviate anxiety, depression, and colitis by mitigating gut dysbiosis (Han & Kim, 2019). (Yong et al., 2020) Lactobacillus rhamnosus , has shown antidepressant effects in both healthy and stressed mice. Studies in postpartum women and obese individuals also reported reduced depressive thoughts with its use. Its positive effects are linked to signaling through the vagus nerve, influencing brain activity and the stress-regulating hypothalamic-pituitary-adrenal (HPA) axis. L. rhamnosus produces Gamma-aminobutyric acid (GABA), a neurotransmitter that helps regulate mood, and can cross the gut barrier to interact with neurons. This probiotic also lowers stress hormones and may help prevent depression by boosting GABA levels and protecting against HPA axis overactivity (Yong et al ., 2020). These studies demonstrate that a specific Lactobacillus strain effectively treats major depressive disorder (MDD) by lowering inflammation and increasing serotonin production. Strength and limitations Strengths Clinical Relevance : Understanding the gut-brain axis has key clinical implications for treating various conditions, including mental health disorders like depression, anxiety, and irritable bowel syndrome (IBS), as well as neurological diseases like Parkinson’s and Alzheimer’s. Therapeutic Potential : Research on the gut-brain axis has led to innovative treatments targeting gut microbiota, including probiotics, prebiotics, and fecal microbiota transplantation (FMT), offering potential for managing gastrointestinal and psychiatric disorders. Advanced Technologies : Cutting-edge tools such as metagenomics, metabolomics, and neuroimaging have enhanced the study of the gut-brain axis, helping researchers uncover the mechanisms of gut-brain communication with greater precision. Limitations Correlational Nature : Much of the research is based on associations between gut microbiota and brain function or behavior, making it difficult to establish causality and deeper understanding. Animal Models : Many gut-brain axis studies use animal models, which may not fully reflect human physiology and behavior. Translating these findings to humans requires careful attention to species differences and limitations. Long-term Effects and Safety : The long-term safety and effects of gut microbiota-targeted interventions for mental health are still unclear. More research is needed to evaluate potential risks and benefits over extended periods. Implications and Applications Probiotic Supplements : Recommending probiotics with beneficial bacteria to help balance gut microbiota. Psychotherapy : Using therapies like cognitive-behavioral therapy (CBT) that address both mental health and gut-brain axis interactions. Medication : Considering medications that influence the gut-brain axis, including specific antidepressants or treatments targeting gut microbial imbalances. Education and Awareness : Informing patients about the link between gut health and mental well-being to help them make better lifestyle choices. Related Research and Future Directions Role in Neurological and Psychiatric Disorders : Exploring the influence of the gut-brain axis on a variety of neurological and psychiatric conditions beyond depression and anxiety, such as Alzheimer's, Parkinson's, autism spectrum disorders, schizophrenia, and bipolar disorder. This research could reveal common underlying mechanisms and highlight new therapeutic options. Gut Microbiota and Brain Development : Examining how gut microbiota impacts brain development and function during key stages like infancy, childhood, and adolescence. Insights into early microbial exposures could guide strategies for enhancing neurodevelopment and brain health. Technological Advances : Utilizing cutting-edge tools like microbiome sequencing, multi-omics profiling, neuroimaging, and computational modeling to delve deeper into gut-brain interactions. Combining diverse data sources will allow for more detailed analyses of complex biological systems. Conclusion With the growing pressures of modern life, depression has become increasingly prevalent, yet a complete cure remains unknown. Research on the gut-brain axis suggests a strong connection between depression and changes in the gut microbiota. Depression can disrupt the gut's microbial balance and potentially trigger complications like IBS. IBS, linked to gut microbiota imbalance, also increases the risk of depression. Adjusting and restoring the gut microbiota composition may help alleviate depressive symptoms. This highlights the importance of investigating microbiota-based treatments for depression (Zhu et al ., 2022). References Agnihotri N, Mohajeri MH. Involvement of Intestinal Microbiota in Adult Neurogenesis and the Expression of Brain-Derived Neurotrophic Factor. Int J Mol Sci. 2022 Dec 14;23(24):15934. doi: 10.3390/ijms232415934. PMID: 36555576; PMCID: PMC9783874. Appleton J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr Med (Encinitas). 2018 Aug;17(4):28-32. PMID: 31043907; PMCID: PMC6469458. Barandouzi ZA, Starkweather AR, Henderson WA, Gyamfi A, Cong XS. Altered Composition of Gut Microbiota in Depression: A Systematic Review. Front Psychiatry. 2020 Jun 10;11:541. doi: 10.3389/fpsyt.2020.00541. PMID: 32587537; PMCID: PMC7299157. Bharwani A, Bala A, Surette M, Bienenstock J, Vigod SN, Taylor VH. Gut Microbiome Patterns Associated With Treatment Response in Patients With Major Depressive Disorder. Can J Psychiatry. 2020 Apr;65(4):278-280. doi: 10.1177/0706743719900464. Epub 2020 Jan 21. PMID: 31958990; PMCID: PMC7385422. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5. doi: 10.1073/pnas.1102999108. Epub 2011 Aug 29. PMID: 21876150; PMCID: PMC3179073. Breit S, Kupferberg A, Rogler G, Hasler G. Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. Front Psychiatry. 2018 Mar 13;9:44. doi: 10.3389/fpsyt.2018.00044. PMID: 29593576; PMCID: PMC5859128. Capuco A, Urits I, Hasoon J, Chun R, Gerald B, Wang JK, Kassem H, Ngo AL, Abd-Elsayed A, Simopoulos T, Kaye AD, Viswanath O. Current Perspectives on Gut Microbiome Dysbiosis and Depression. Adv Ther. 2020 Apr;37(4):1328-1346. doi: 10.1007/s12325-020-01272-7. Epub 2020 Mar 4. PMID: 32130662; PMCID: PMC7140737. Chand SP, Arif H. Depression. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/ Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554406/ Crowell MD, Wessinger SB. 5-HT and the brain-gut axis: opportunities for pharmacologic intervention. Expert Opin Investig Drugs. 2007 Jun;16(6):761-5. doi: 10.1517/13543784.16.6.761. PMID: 17501688. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999 Sep;14(9):569-80. doi: 10.1046/j.1525-1497.1999.03478.x. PMID: 10491249; PMCID: PMC1496741. Han SK, Kim DH. Lactobacillus mucosae and Bifidobacterium longum Synergistically Alleviate Immobilization Stress-Induced Anxiety/Depression in Mice by Suppressing Gut Dysbiosis. J Microbiol Biotechnol. 2019 Sep 28;29(9):1369-1374. doi: 10.4014/jmb.1907.07044. PMID: 31564078. InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Depression: Learn More – Treatments for depression. [Updated 2020 Jun 18]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279282/ Kendig DM, Grider JR. Serotonin and colonic motility. Neurogastroenterol Motil. 2015 Jul;27(7):899-905. doi: 10.1111/nmo.12617. PMID: 26095115; PMCID: PMC4477275. Lattimore, Keri & Donn, Steven & Kaciroti, Niko & Kemper, Alex & Neal, Charles & Vázquez, Delia. (2005). Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis. Journal of perinatology : official journal of the California Perinatal Association. 25. 595-604. 10.1038/sj.jp.7211352. Liu N, Sun S, Wang P, Sun Y, Hu Q, Wang X. The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine. Int J Mol Sci. 2021 Jul 25;22(15):7931. doi: 10.3390/ijms22157931. PMID: 34360695; PMCID: PMC8347425. McVey Neufeld, KA., Bienenstock, J., Bharwani, A. et al. Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling. Sci Rep 9, 14290 (2019). https://doi.org/10.1038/s41598-019-50807-8 Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013 Jun;12(2):92-8. doi: 10.1002/wps.20050. PMID: 23737408; PMCID: PMC3683251. Yong SJ, Tong T, Chew J, Lim WL. Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential. Front Neurosci. 2020 Jan 14;13:1361. doi: 10.3389/fnins.2019.01361. PMID: 32009871; PMCID: PMC6971226. Zheng P, Yang J, Li Y, Wu J, Liang W, Yin B, Tan X, Huang Y, Chai T, Zhang H, Duan J, Zhou J, Sun Z, Chen X, Marwari S, Lai J, Huang T, Du Y, Zhang P, Perry SW, Wong ML, Licinio J, Hu S, Xie P, Wang G. Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression. Adv Sci (Weinh). 2020 Feb 5;7(7):1902862. doi: 10.1002/advs.201902862. PMID: 32274300; PMCID: PMC7140990. Zhu F, Tu H, Chen T. The Microbiota-Gut-Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect. Nutrients. 2022 May 16;14(10):2081. doi: 10.3390/nu14102081. PMID: 35631224; PMCID: PMC9144102.
- Are High-Frequency Devices Science-Backed or Skincare Hype?
In the era of elaborate skincare routines, consumer trends often outpace evidence-based science. Research on popular high frequency (HF) devices, such as the wands commonly used for acne treatment, may offer valuable insights into their true effects on the skin microbiome. What We Know: Developed in the 19th century, HF therapy gained attention for its potential benefits in supporting lymphatic drainage, preventing hair loss and reducing wrinkles. By the early 20th century, it was recognised as a versatile treatment for various conditions, including skin infections, eczema and wounds, as well as ailments like migraines, neuralgia and even tuberculosis (Napp et al., 2015) . HF devices, also known as Violet Wands, function by delivering Cold Atmospheric Pressure Plasma (CAPP) to the site of application, such as the face. This process releases bioactive components, including charged particles and reactive species like ozone and nitrogen oxides (Frommherz et al., 2022). HF therapy ultimately lost popularity in the mid-20th century due to the rise of antibiotics and limited efficacy data. However, with increasing antibiotic resistance, plasma medicine (or CAPP) is gaining renewed interest. Recent studies suggest that HF devices may outperform traditional antiseptics in targeting wound pathogens, raising questions about their potential benefits for acne-prone skin and their impact on the skin microbiome (Daeschlein et al., 2015) . Industry Impact and Potential: Recent research has demonstrated that HF therapy possesses a microbicidal effect on skin microbiota and pathogens in vitro , significantly reducing bacterial and fungal counts after just a brief treatment. Notably, one minute of HF application led to a significant reduction in C. acnes levels (Frommherz et al., 2022) . It is hypothesised that HF therapy increases ozone formation during application, suggesting that its primary antimicrobial effects stem from ozone and the oxidative stress it induces in microbes. Ozone is also recognised for its anti-inflammatory properties, further enhancing its efficacy in treating skin conditions (Frommherz et al., 2022) . Ultimately, the antiseptic properties of HF therapy present a promising alternative to antibiotics for managing conditions like acne ( Frommherz et al., 2022) . However, it is important to remember that not all HF devices available, especially cheaper options, are created equal; variations in voltage, frequency and design can affect their efficacy and safety. Our Solution: With a database of 25,000 microbiome samples and 4,000 ingredients, plus a global network of testing participants, Sequential provides customised solutions for microbiome studies and product formulation. Our commitment to developing microbiome-safe products ensures the preservation of biome integrity, making us an ideal partner investigating the skin, scalp, oral and vaginal microbiome. References: Daeschlein, G., Napp, M., von Podewils, S., Scholz, S., Arnold, A., Emmert, S., Haase, H., Napp, J., Spitzmueller, R., Gümbel, D. & Jünger, M. (2015) Antimicrobial Efficacy of a Historical High-Frequency Plasma Apparatus in Comparison With 2 Modern, Cold Atmospheric Pressure Plasma Devices. Surgical Innovation . 22 (4), 394–400. doi:10.1177/1553350615573584. Frommherz, L., Reinholz, M., Gürtler, A., Stadler, P.-C., Kaemmerer, T., French, L. & Clanner-Engelshofen, B.M. (2022) High-frequency devices effect in vitro: promissing approach in the treatment of acne vulgaris? Anais Brasileiros de Dermatologia . 97, 729–734. doi:10.1016/j.abd.2021.09.015. Napp, J., Daeschlein, G., Napp, M., von Podewils, S., Gümbel, D., Spitzmueller, R., Fornaciari, P., Hinz, P. & Jünger, M. (2015) On the history of plasma treatment and comparison of microbiostatic efficacy of a historical high-frequency plasma device with two modern devices. GMS hygiene and infection control . 10. doi:10.3205/dgkh000251.
- Aromatic Answers: Can the Oral Microbiome Alter How We Perceive Scent and Taste?
Recent research into aroma perception - the process by which the brain detects scent molecules from food - has primarily focused on the physical and chemical properties of these substances and their release during chewing. However, the role of the oral microbiome in this process is still underexplored, offering new insights into how microorganisms shape the flavours we experience. What We Know: While taste is detected by the tongue’s taste buds, aroma involves volatile compounds released from food that are detected by olfactory receptors in the nose. Aroma significantly enhances flavour, allowing us to distinguish foods with similar tastes. During chewing, aroma compounds travel from the mouth to the nasal cavity (retronasal olfaction), blending with taste to create a complete sensory experience (Xi et al., 2024) . The oral microbiome plays a crucial role in aroma perception. These microorganisms interact with food compounds in various ways, such as breaking down odourless molecules and transforming them into volatile compounds that we perceive as aroma. Moreover, the oral microbiota influences how taste and smell signals are processed by the brain, further affecting overall flavour perception (Xi et al., 2024) . Emerging research indicates that oral microbiota help metabolise complex food precursors, such as glycosides, into flavour-active molecules during chewing. A balanced oral microbiome enhances flavour perception, while an imbalance may dull or alter this sensory experience (Xi et al., 2024) . Industry Impact and Potential: Research is still in infancy regarding the role of the oral microbiome in aroma perception. Therefore, harnessing the power of oral bacteria to enhance flavours or create novel sensory experiences is a promising avenue of exploration. Furthermore, understanding how the oral microbiome contributes to the perception of scent and taste could also lead to the development of targeted oral care products that maintain or improve flavour perception by supporting a healthy microbiome. A company that harnesses the intricate relationship between taste, scent, and retronasal olfaction is @air up®, which has developed innovative water bottles featuring built-in scent-releasing pods. This design allows users to enjoy unflavoured water while experiencing specific flavours, as the released scents interact with the olfactory system to create a taste sensation in the mouth. Our Solution: Sequential is a leading authority in microbiome product testing and formulation, offering customisable solutions that empower businesses to innovate oral hygiene products while preserving microbiome integrity. We ensure the efficacy and compatibility of products for a healthier oral microbiome, making us the ideal partner to help your company explore the potential of oral, as well as skin, scalp and vaginal, microbiome studies and product development. References: Xi, Y., Yu, M., Li, X., Zeng, X. & Li, J. (2024) The coming future: The role of the oral–microbiota–brain axis in aroma release and perception. Comprehensive Reviews in Food Science and Food Safety . 23 (2), e13303. doi:10.1111/1541-4337.13303.
- Prospects for Vaginal Bacteriosis: Are New Treatments Emerging After 40 Years of Stagnancy?
Bacterial vaginosis (BV) affects over half of women globally at some point in their lives, primarily due to a Lactobacillus -deficient vaginal microbiome. Despite this knowledge, there have been no significant advancements in effective BV treatments for nearly four decades, making this a critical area of research and interest. What We Know: BV is characterised by an imbalance in the vaginal microbiome, marked by a low abundance of beneficial Lactobacilli and an overgrowth of diverse anaerobic bacteria. This imbalance leads to clinical symptoms such as discharge, odour and mucosal inflammation. BV is also linked to several adverse health outcomes, including preterm birth, infertility, cervical dysplasia and increased susceptibility to sexually transmitted infections (STIs), including HIV (Zhu et al., 2024) . Standard antibiotic treatments, like metronidazole (MTZ), often fail to provide lasting relief, with over 50% of patients experiencing recurrence within a year. This is partly because antibiotics tend to favour the growth of Lactobacillus iners over Lactobacillus crispatus , the latter being associated with better health outcomes (Zhu et al., 2024) . Industry Impact and Potential: Recent research has shown that oleic acid (OA) and similar unsaturated long-chain fatty acids (uLCFAs) can inhibit L. iners while simultaneously promoting the growth of L. crispatus. These uLCFAs are essential for cell membranes and possess antimicrobial properties that suppress harmful microbes. Remarkably, OA has been found to encourage L. crispatus dominance more effectively than traditional antibiotics in laboratory models of BV, suggesting a promising metabolite-based treatment approach (Zhu et al., 2024). Specific genes in non-iners Lactobacillus species allow them to thrive in OA-rich environments. The gene farE is crucial for OA resistance, while the enzyme ohyA helps these bacteria utilise OA for building their cell membranes. Importantly, treatments for BV that include OA - alone or in combination with metronidazole (MTZ) - enhance the growth of beneficial L. crispatus in lab studies. This research highlights different nutrient utilisation strategies among Lactobacillus species and points to new approaches for improving women’s reproductive health (Zhu et al., 2024). Our Solution: At Sequential, we are at the forefront of microbiome research and development, offering comprehensive services beyond vaginal microbiome analysis. We also evaluate skin, scalp and oral microbiomes, establishing our leadership in testing products that maintain microbiome integrity. Our team of specialists excels in helping your company develop robust studies tailored to enhance the vaginal microbiome, promoting women's health and well-being. References: Zhu, M., Frank, M.W., Radka, C.D., Jeanfavre, S., Xu, J., et al. (2024) Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment. Cell . 187 (19), 5413-5430.e29. doi:10.1016/j.cell.2024.07.029.
- Microplastics vs. Microbiome: Is Your Skin Fighting a Losing Battle Against Environmental Pollution?
Microplastics, the small plastic debris that result from the breakdown of consumer products and industrial waste, are widely recognised for their harmful environmental effects. However, little research has explored how these particles - which are found in up to 70% of cosmetic products - affect the skin microbiome. What We Know: Microplastics are tiny, solid plastic particles composed of polymers and additives. They are typically less than 5 mm and can be unintentionally formed through the wear and tear of larger plastic items (@European Chemicals Agency, 2024). These particles, including microbeads and fibres, are commonly found in personal care products like shower gels, toothpaste and nail polish and include polyethylene, polyethylene terephthalate and polypropylene. Microplastics serve various roles, from exfoliating beads in scrubs to enhancing product texture and stability, and even as glitter in makeup (Mim et al., 2024; Bashir et al., 2021). In Europe, it’s estimated that around 3800 tonnes of microplastics are released into the environment annually through everyday cosmetic and personal care products (@European Chemicals Agency, 2024). Microplastics can adsorb organic and inorganic contaminants on their surfaces, where biofilms may form, potentially acting as carriers of pathogenic vectors, pollutants, antimicrobial resistance, microorganisms and resistance genes. This raises concerns about how these particles may interact with the skin microbiome when present in cosmetic products (Mim et al., 2024). Additionally, nanoplastics - smaller than microplastics, typically around 100 nm or less - can potentially penetrate biological barriers and may have toxic effects when present in topical products (Yong, Valiyaveettil & Tang, 2020). Industry Impact and Potential: Research on the impact of microplastics on the gut microbiome has shown that these particles can lead to significant shifts, including increased α-diversity and higher levels of potentially harmful pathobionts. As a result, it is widely hypothesised that microplastics may also be detrimental to the skin microbiome. However, further research is essential to elucidate the mechanisms behind these effects (Mim et al., 2024). @Beat the Microbead is an innovative app developed by the @Plastic Soup Foundation that enables users to scan cosmetic product barcodes to check for microplastics. This empowers consumers to take control of their microplastic exposure and make informed choices, even before regulations and legislation fully address the issue. Our Solution: Sequential is a global leader in microbiome product development and testing, with locations in London, New York and Singapore. Our expertise and customisable services allow businesses to innovate confidently, ensuring their products preserve microbiome integrity and meet specific goals, such as efficacy, compatibility and environmental sustainability. References: Bashir, S.M., Kimiko, S., Mak, C.-W., Fang, J.K.-H. & Gonçalves, D. (2021) Personal Care and Cosmetic Products as a Potential Source of Environmental Contamination by Microplastics in a Densely Populated Asian City. Frontiers in Marine Science. 8. doi:10.3389/fmars.2021.683482. Mim, M.F., Sikder, M.H., Chowdhury, M.Z.H., Bhuiyan, A.-U.-A., Zinan, N. & Islam, S.M.N. (2024) The dynamic relationship between skin microbiomes and personal care products: A comprehensive review. Heliyon. 10 (14). doi:10.1016/j.heliyon.2024.e34549. Yong, C.Q.Y., Valiyaveettil, S. & Tang, B.L. (2020) Toxicity of Microplastics and Nanoplastics in Mammalian Systems. International Journal of Environmental Research and Public Health. 17 (5), 1509. doi:10.3390/ijerph17051509.
- One Size Doesn’t Fit All: The Applications and Benefits of Personalised Skincare
Every person’s skin is unique, shaped by genetics, the environment and lifestyle factors. Research demonstrates that personalised skincare, particularly when tailored to the skin microbiome, delivers more effective and lasting results by addressing each individual’s specific needs, promoting healthier and more resilient skin. What We Know: Human skin varies significantly due to genetic differences, which influence how it responds to environmental stressors, its susceptibility to ageing and its reactions to skincare products. These genetic variations are closely linked to factors like skin pigmentation, structure and sensitivity to UV radiation (Markiewicz & Idowu, 2018). Personalised skincare addresses these individual differences by tailoring products and treatments to each person's unique needs. This approach is gaining popularity in the cosmetics industry as it offers more effective and targeted solutions than generic skincare products. The primary benefits of personalised skincare include improved efficacy, as products are customised to match individual skin characteristics, and enhanced protection against environmental damage and ageing. By catering to the specific needs of different skin types, personalised skincare can also more effectively prevent or mitigate skin conditions (Markiewicz & Idowu, 2018). Industry Impact and Potential: A study that investigated the use of microbiome-tailored skincare products found that these products significantly enhanced skin health by supporting a more diverse and balanced skin microbiome. In the study, participants used microbiome-supporting (MS) products on one cheek and benchmark (BM) products on the other for three weeks. The results showed that the MS products led to a notable increase in beneficial bacterial diversity, reduced skin redness and improved skin texture. In contrast, the BM products only provided minor improvements in skin texture and did not significantly impact other skin health parameters (Santamaria et al., 2023). Parallel Health uses whole genome sequencing to analyze an individual’s skin microbiome, creating customized phage-based skincare solutions. These serums target harmful bacteria causing issues like acne and rosacea while supporting beneficial microbes. The process includes a microbiome test, personalized consultations, ongoing skin assessments, and tailored serums for continuous skin health. Our Solution: Sequential's personalised skincare approach harnesses the power of microbiome-based facial products through its comprehensive Microbiome Product Testing Solution. This end-to-end service supports both independent testing and expert-guided formulation, enabling businesses to develop innovative, tailored skincare solutions that cater to individual microbiomes. References: Markiewicz, E. & Idowu, O.C. (2018) Personalized skincare: from molecular basis to clinical and commercial applications. Clinical, Cosmetic and Investigational Dermatology. 11, 161–171. doi:10.2147/CCID.S163799. Santamaria, E., Åkerström, U., Berger-Picard, N., Lataste, S. & Gillbro, J.M. (2023) Randomized comparative double-blind study assessing the difference between topically applied microbiome supporting skincare versus conventional skincare on the facial microbiome in correlation to biophysical skin parameters. International Journal of Cosmetic Science. 45 (1), 83–94. doi:10.1111/ics.12826.
- That’s Fishy: The Powerful Role of Marine Collagen in Wound Healing
Collagen is widely celebrated in the skincare industry for its anti-ageing and rejuvenating benefits. Recent research reveals that marine collagen peptides, used both orally and topically, support wound healing and may enhance skin health by modulating the skin microbiome. What we know: Collagen, the most abundant protein in the human body, comprises 30% of total protein content. Oral hydrolysed collagen boosts collagen peptides in the bloodstream, improving skin elasticity, hydration, and reducing water loss. Topically, it moisturizes the stratum corneum, reduces dryness and wrinkles, and enhances skin elasticity ( Gabriel Aguirre Alvarez et al., 2020). Skin wounds pose a major socio-economic challenge in healthcare. Treatments include collagen alginate dressings, silver sulfadiazine cream, autografts, allografts, and xenografts. Acellular fish skin (AFS) grafts have recently gained attention as a cost-effective option, acting as a 'skin substitute' that reduces inflammation and promotes pro-healing cytokines to improve wound recovery ( Hanna Luze et al., 2022). The expression of nucleotide-binding oligomerization domain containing 2 (NOD2) and β-defensin (BD14) at the wound site directly affect the types of microorganisms that colonise wound (Mei et al., 2020). Industry impact and potential: A new xenograft technique utilising AFS grafts from Atlantic cod or Nile tilapia fish has shown promising results in wound healing. These grafts have demonstrated significant anti-inflammatory and antibacterial properties, which enhance the healing process for various types of wounds, including burns and DFUs. Current research is focused on comparing the effectiveness of fish skin grafts with other wound healing methods (Ibrahim et al., 2023). Research shows that oral collagen peptides from Atlantic salmon and Nile tilapia skin accelerate wound healing by upregulating NOD2 and BD14, key to immune response and skin repair. These peptides enhance collagen deposition, angiogenesis, and promote beneficial microbes like Leuconostoc and Enterococcus while suppressing harmful ones like Stenotrophomonas and Sphingomonas, improving overall wound healing outcomes (Mei et al., 2020). Products such as ELEMIS ‘Pro-Collagen Marine Cream’ and Naturallythinking ‘Marine Collagen Facial Cream’ are examples of topical approaches to utilising these beneficial collagen peptides. Further research into the benefits of topical and oral marine collagen for skin health, beyond wound healing, presents an exciting opportunity—especially in exploring its impact on the skin microbiome. Our solution: Sequential provides a unique end-to-end microbiome product testing solution, complemented by specialised product development and formulation services. Leveraging our expertise, we assist businesses in creating innovative skin products, such as collagen-containing wound healing solutions, that preserve microbiome integrity and promote overall skin health. References: Aguirre-Cruz, G., León-López, A., Cruz-Gómez, V., Jiménez-Alvarado, R. & Aguirre-Álvarez, G. (2020) Collagen Hydrolysates for Skin Protection: Oral Administration and Topical Formulation. Antioxidants (Basel, Switzerland). 9 (2), 181. doi:10.3390/antiox9020181. Ibrahim, M., Ayyoubi, H.S., Alkhairi, L.A., Tabbaa, H., Elkins, I. & Narvel, R. (2023) Fish Skin Grafts Versus Alternative Wound Dressings in Wound Care: A Systematic Review of the Literature. Cureus. 15 (3), e36348. doi:10.7759/cureus.36348. Luze, H., Nischwitz, S.P., Smolle, C., Zrim, R. & Kamolz, L.-P. (2022) The Use of Acellular Fish Skin Grafts in Burn Wound Management-A Systematic Review. Medicina (Kaunas, Lithuania). 58 (7), 912. doi:10.3390/medicina58070912. Mei, F., Liu, J., Wu, J., Duan, Z., Chen, M., Meng, K., Chen, S., Shen, X., Xia, G. & Zhao, M. (2020) Collagen Peptides Isolated from Salmo salar and Tilapia nilotica Skin Accelerate Wound Healing by Altering Cutaneous Microbiome Colonization via Upregulated NOD2 and BD14. Journal of Agricultural and Food Chemistry. 68 (6), 1621–1633. doi:10.1021/acs.jafc.9b08002.











